The Food and Drug Administration is changing industry guidance for beef cattle implants. After June, the FDA will redefine the production phases for beef cattle, which will affect the label claims of existing and new drugs. The production phases are important because the new guidance will allow beef cattle to receive one implant for each production phase. “This affects implants for beef cattle production because they are considered a drug,” said Zac Carlson, beef cattle specialist, NDSU Extension. More details will be released soon.
